거래 정지 중인 종목 2026-06-04 이후 거래가 정지되었습니다. 재개될 수 있으며, 표시된 시세는 마지막 거래일 기준입니다.
IINN
Inspira Technologies Oxy B.H.N. Ltd
$0.38
+0.01 ▲ +1.93%
인스피라텍(IINN) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
시가총액
$17M
스몰캡
P/E
-
배당수익률
없음
52주 위치
3%
저점 +13% · 고점 -77%
애널리스트
적극 매수
B+
Fundamental health
vs. Medical Devices 초소형주· based on 3 axes
수익성 산출 불가 (적자)
성장 Top 33%
밸류에이션 Top 8%
재무 안정 Top 44%
| Index | - | P/E | - | EPS (ttm) | -0.45 | Insider Own | 3.82% | Shs Outstand | 43.6M | Perf Week | -9.21% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 41.9M | Perf Month | -35.33% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | -0.03 | Inst Own | 14.69% | Short Float | 2.16% | Perf Quarter | -34.48% |
| Income | -0.01B | P/S | 57.01 | EPS this Y | 122.22% | Inst Trans | 15.32% | Short Ratio | 3.04 | Perf Half Y | -59.67% |
| Sales | 0.00B | P/B | 5.87 | EPS next 5Y | - | ROA | -197.15% | Short Interest | 0.91M | Perf YTD | -57.83% |
| Book/sh | 0.06 | P/C | 5.07 | EPS past 3/5Y | 31.48% 14.99% | ROE | -397.89% | 52W High | -77% ($1.65) | Perf Year | -25.49% |
| Cash/sh | 0.07 | P/FCF | - | Sales past 3/5Y | - | ROIC | -525.23% | 52W Low | 13.18% ($0.34) | Perf 3Y | -73.46% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 25.24% | Gross Margin | -154.67% | Volatility(W/M) | 7.82% 11.03% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 51.15 | Sales Y/Y TTM | - | Oper. Margin | -4710.73% | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.3 | EPS Q/Q | 95.19% | Profit Margin | -4574.39% | RSI (14) | 34.98 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.56 | Sales Q/Q | - | SMA20 | -16.21% ($0.45) | Beta | 2.13 | Target Price | $5 |
| Payout | - | Debt/Eq | 0.67 | Earnings | 2026/3/26 | SMA50 | -21.72% ($0.49) | Rel Volume | 3.9 | Prev Close | $0.37 |
| Employees | 40 | LT Debt/Eq | 0.08 | EPS/Sales Surpr. | -5% -100% | SMA200 | -56.43% ($0.87) | Avg Volume(3M) | 0.30M | Price | $0.38 |
| IPO | 2021/7/14 | Option/Short | No/Yes | Trades | 1196 | Volume | 1,163,508 | Change | 1.93% |
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.
Inspira Technologies Oxy B.H.N. Ltd (IINN) Investment Analysis
What kind of company is Inspira Technologies Oxy B.H.N. Ltd?
인스피라텍(IINN)
Healthcare · Medical Devices
Small-Cap — Low Volume, High Volatility
🫁 This Israel-based medical device company develops and supplies the FDA-approved blood oxygenation and respiratory support system 'INSPIRA ART100', designed to address the limitations of conventional ventilators and ECMO, along with a real-time blood monitoring solution.
Learn more about Inspira Technologies Oxy B.H.N. Ltd →Market Cap
$0.0B
Approx. KRW 0.0 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank5329
Employees40people
IPO2021/07/14
Current Price$0.38 ≈ 521원
Key Events
⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 3월 26일 (목) · 장 마감 후 EPS -5.0% 매출 -100.0%
Is it profitable?
Financially sound but profitability is low
Losses or thin margins — early-stage growth or weakening competitiveness
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
-4710.7%
✓ 적자
Net Margin
Share of revenue left after taxes and interest are paid
-4574.4%
✓ 적자
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
-154.7%
✓ 부진
ROE
Annual return earned on shareholders' equity (15%+ is strong)
-397.9%
✓ 적자
ROA
Annual earnings relative to total company assets
-197.2%
✓ 적자
ROIC
Return generated per dollar invested in the business
-525.2%
✓ 적자
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.67
✓ Average
Current Ratio
Liquid assets available to cover liabilities due within a year
1.56
✓ 양호
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.30
✓ 양호
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).
What's the outlook?
Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$5.00
현재가 대비 +1215.8%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.
Did earnings meet expectations?
High Earnings Volatility
Frequently misses analyst estimates
0
예상 상회
0
예상 부합
1
예상 하회
0%
상회 비율
-5.0%
평균 서프라이즈
2026.03.26
하회
-5.0%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.
Is it growing?
Strong Growth
Above the industry average, both historically and going forward
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+122.2%
우수
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+31.5%
양호
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
+15.0%
양호
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →
Has the stock risen over the long term?
Underperformed the market by 41%p over the past year
IINN -25.5% · S&P 500 +16.0%
Excess return vs. market (price-based, ex-dividends)
1-year basis
vs S&P 500
-41.5%p
Significantly behind the market
vs Health Care (XLV)
-45.2%p
Significantly behind the sector average
Rank among peers
1-year return Top 20% Based on 68 peers
Current position within 52-week range
Low (-13.2%p) High (-77.0%p)
Current price is 13.2% above the 52-week low and 77.0% below the 52-week high
Recent risk (last 83 trading days)
Max drawdown
-53.8%
Annualized volatility
95.1%
Technical Indicators
Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 90-day series
Price · Bollinger Bands · Ichimoku Cloud
- close
- BB Upper
- BB Mid
- BB Lower
- Tenkan
- Kijun
- Cloud (SpanA/B)
Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →
MACD (12 · 26 · 9) Expand ▼
An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →
RSI(14) · Stochastics %K(14) Expand ▼
RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →
※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.
Is it attractive at this price?
Pricier than peers in its industry
Pricey on Vs. Assets·Vs. Sales
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
Vs. Assets Pricey
Vs. Sales Pricey
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
5.87x
✓ Pricey
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
57.01x
✓ Very pricey
Analyst target price (reference)
$5.00 vs. current price +1215.8%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Devices 초소형주
Who owns it?
Ownership flow is positive
Institutional net buying +15.3% · Short interest light 2.2% · Short interest up +1.4pp over last 83d
📈 Recent trading flow (6 months)
🧑💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
+15.3%
Institutions large net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 14.7%
Retail-led
🧑💼 Insiders 3.8%
Typical level
👤 Retail investors (estimated) 81.5%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
2.2%
Low — limited short-side pressure
Past 83 days 📈 +1.4%p increase
Short interest days to cover
3.0 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 43.6M주
Float (tradable shares) 41.9M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 83 days.
How much does it pay in dividends?
This company does not pay a dividend
It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.
Compare Industry Peers
💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
| Stock | Market Cap | PER | PBR | ROE | Dividend Yield | Change |
|---|---|---|---|---|---|---|
| IINN This Stock | $16.5M | - | 5.9 ▼ | -397.89% ▼ | - | +1.9% |
LLY | $1.13T | 43.1 ▼ | 36.2 ▼ | 107.64% ▲ | 0.58% ▼ | +0.1% |
JNJ | $640.9B | 30.8 ▼ | 7.5 ▼ | 25.74% ▲ | 2.02% ▲ | +1.0% |
ABBV | $453.9B | 126.7 ▼ | - | 15221.82% ▲ | 2.67% ▲ | -0.9% |
UNH | $379.3B | 26.9 ▼ | 3.9 ▼ | 12.49% ▲ | 2.16% ▲ | -0.7% |
MRK | $323.0B | 36.8 ▼ | 7.0 ▼ | 18.97% ▲ | 2.5% ▲ | -0.2% |
| Sector Avg | - | 26.1 | 2.7 | -48.83% | 1.23% | - |
FAQ
What kind of company is 인스피라텍(IINN)?
인스피라텍(IINN) belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of IINN?
The market cap of IINN is approximately $17M, ranking 5,329 within its sector.
What is the 52-week high and low for IINN?
IINN has recorded a 52-week high of $1.65 and a low of $0.34.
면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.